HONG KONG,Jan. 23,2025-- Hong Kong Productivity Council (HKPC) in collaboration with the Hong Kong Computer Emergency Response Team Coordination Centre (HKCERT),and Digital Policy Office of the HKSAR
LG Energy Solution Releases 2024 Financial Results
LG Energy Solution posts KRW 25.6 trillion in consolidated revenue and KRW 575.4 billion in operating profit in 2024
PLEASANTON,Calif.,Jan. 20,2025-- As Valentine\'s Day approaches,finding the perfect gift for your loved one can be challenging. Why not go for something unique,thoughtful,and practical? Enter theDermR
The 15th Spring Festival Book Exposition held around the world
BEIJING,Jan. 20,2025-- During the Chinese New Year of 2025,the 15th Spring Festival Book Exposition organized by China National Publications Import & Export (Group) Co.,Ltd (CNPIEC) was held succe
HONG KONG,Jan. 20,2025-- Hong Kong Airlines resumed direct flights to Vancouver,Canada,on 18 January. Celebrations were held at Hong Kong International Airport and Vancouver International Airport to
HKBN InnoTech Ecosystem Alliance Officially Launched
Unite Leading Tech Enterprises to Accelerate Innovation & Growth HONG KONG,Jan. 20,2025-- HKBN Enterprise Solutions today hosted the launch ceremony for the "HKBN InnoTech Ecosystem Alliance
Saasyan Introduces New Reseller Partner Program
SYDNEY,Jan. 20,2025-- Saasyan,a leader in AI-powered online student safety,has announced the reintroduction of their reseller partner program after a three-year hiatus.
Sungrow Hydrogen won the largest supply contract for the 320MW green ammonia project in Oman!
HEFEI,China,Jan. 20,2025--On January 18th,Sungrow Hydrogen signed supply agreement with ACME Groupand willprovide water electrolysis hydrogen production equipment for the 320MW green ammonia project i
MicroAire Completes Acquisition of NEOSYAD
CHARLOTTESVILLE,Va.,Jan. 21,2025-- MicroAire Surgical Instruments,the global leader in power-assisted liposuction,is pleased to announce the acquisition of NEOSYAD,an innovative medical device compa
CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial
SHANGHAI,Jan. 20,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors